Catalyst Wire Dossier Catalyst Wire Dossier

Trontinemab

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Trontinemab, covering 2026-04-03 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease [Phase 3]

See pricing